IV CR845: Phase III started

Cara began the double-blind, U.S. Phase III CLIN3001 trial to evaluate 1, 2 and 5 ug/kg IV CR845 in up to 600 patients undergoing hysterectomy, prostatectomy, hemi-colectomy or ventral hernia surgery....